Characterizing immune-genomic signatures associated with response to immune checkpoint inhibitors (ICI) in patients with metastatic urothelial carcinoma (mUC)

被引：0
|
作者：
Pramod, Nikhil
Dawsey, Scott
Pavicic, Paul G.
Lodha, Roshan
Patgunarajah, Ubenthira
Nair, Monica
Ornstein, Moshe Chaim
Gilligan, Timothy D.
Wee, Christopher Eing
Mian, Omar Y.
Nizam, Amanda
Nguyen, Jane
Diaz-Montero, C. Marcela
Gupta, Shilpa
机构：
[1] Cleveland Clin, Lerner Coll Med, Cleveland, OH USA
[2] John D Dingell VA Hosp, Detroit, MI USA
[3] Cleveland Clin, Cleveland, OH USA
[4] Cleveland Clin, Lerner Res Inst, Cleveland, OH USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16582
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Immunological correlates of response to immune checkpoint inhibitors (ICI) in metastatic urothelial carcinoma (mUC) patients (pts)
    Tzeng, Alice
    Diaz-Montero, C. Marcela
    Rayman, Patricia A.
    Kim, Jin Sub
    Pavicic, Paul G.
    Finke, James
    Barata, Pedro C.
    Lamenza, Marcelo
    Devonshire, Sarah
    Schach, Kim
    Emamekhoo, Hamid
    Ernstoff, Marc S.
    Hoimes, Christopher J.
    Rini, Brian I.
    Garcia, Jorge A.
    Gilligan, Timothy D.
    Ornstein, Moshe Chaim
    Grivas, Petros
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [2] Characterization of genomic alterations as biomarkers of immune checkpoint inhibitor (ICI) response in metastatic urothelial carcinoma (mUC).
    Labriola, Matthew
    Zhu, Jason
    Gupta, Rajan
    McCall, Shannon
    Jackson, Jennifer
    White, James R.
    Weingartner, Elizabeth
    Kong, Eric
    Simone, Peter
    Papp, Eniko
    Gerding, Kelly
    Simmons, John
    George, Daniel J.
    Zhang, Tian
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [3] Genomic correlates of response and resistance to immune checkpoint inhibitors (ICI) in patients with metastatic urothelial carcinoma (mUC) in a real-world setting.
    Pramod, Nikhil
    Makarov, Vladimir
    Dawsey, Scott
    Pavicic, Paul G.
    Patgunarajah, Ubenthira
    Nair, Monica
    Ornstein, Moshe Chaim
    Gilligan, Timothy D.
    Wee, Christopher Eing
    Nizam, Amanda
    Mian, Omar Y.
    Nguyen, Jane
    Diaz-Montero, C. Marcela
    Gupta, Shilpa
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 670 - 670
  • [4] Treatment and outcome after Immune checkpoint inhibitors (ICI) in metastatic Urothelial Carcinoma (mUC): A European perspective
    Lista, A. Gomez de Liano
    Necchi, A.
    Lavaud, P.
    Carles Galceran, J.
    Castellano, D.
    Ravaud, A.
    Duran, I.
    van Dijk, N.
    Giannatempo, P.
    Loriot, Y.
    Morales Barrera, R.
    De Velasco Oria De Rueda, G.
    Lefort, F.
    Martinez Bernal, G.
    Raggi, D.
    Gross-Goupil, M.
    Powles, T.
    van der Heijden, M.
    [J]. ANNALS OF ONCOLOGY, 2017, 28
  • [5] Biomarkers of the Response to Immune Checkpoint Inhibitors in Metastatic Urothelial Carcinoma
    Chen, Siteng
    Zhang, Ning
    Wang, Tao
    Zhang, Encheng
    Wang, Xiang
    Zheng, Junhua
    [J]. FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [6] Effect of concurrent proton pump inhibitors (PPI) use in patients (pts) treated with immune checkpoint inhibitors (ICI) for metastatic urothelial carcinoma (mUC)
    Morales-Barrera, Rafael
    Vidal Casinello, Natalia
    Bonfill, Teresa
    Domenech, Montserrat
    Suarez Rodriguez, Cristina
    Puente, Javier
    Giner Joaquin, Julia
    Figols, Mariona
    Galante, Isabel
    Carrion, Albert
    Lopez, Hector
    Gonzalez, Macarena
    Roche, Sarai
    Mateo, Joaquin
    Gallardo Diaz, Enrique
    Fernandez Saez, Carlos
    Valverde Morales, Claudia Maria
    de Torres, Ines
    Morote, Juan
    Carles, Joan
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [7] The role of previous radical local treatment (RLT) on the outcome of immune checkpoint inhibitors (ICI) in patients (pts) with metastatic urothelial carcinoma (mUC)
    Morales-Barrera, Rafael
    Vidal Casinello, Natalia
    Domenech, Montserrat
    Bonfill, Teresa
    Puente, Javier
    Figols, Mariona
    Giner Joaquin, Julia
    Gonzalez, Macarena
    Lozano, Fernando
    Lopez, Hector
    Galante, Isabel
    Mast, Richard
    Serra Hernandez, Ester
    Eugenia Semidey, Maria
    Serrano, Cesar
    Gallardo Diaz, Enrique
    Suarez Rodriguez, Cristina
    Maldonado, Xavier
    Morote, Juan
    Carles, Joan
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [8] Immunological correlates of response and immune-mediated toxicity in checkpoint inhibitor (ICI)-treated metastatic urothelial carcinoma (mUC) patients (pts).
    Nizam, Amanda
    Tzeng, Alice
    Wei, Wei
    Rayman, Patricia A.
    Pavicic, Paul G.
    Makarov, Vladimir
    Juric, Ivan
    Alban, Tyler
    Swaidani, Shadi
    Sheng, Iris Yeong-Fung
    Gilligan, Timothy D.
    Gupta, Shilpa
    Diaz-Montero, C. Marcela
    Ornstein, Moshe Chaim
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [9] Immunological Correlates of Response to Immune Checkpoint Inhibitors in Metastatic Urothelial Carcinoma
    Alice Tzeng
    C. Marcela Diaz-Montero
    Patricia A. Rayman
    Jin S. Kim
    Paul G. Pavicic
    James H. Finke
    Pedro C. Barata
    Marcelo Lamenza
    Sarah Devonshire
    Kim Schach
    Hamid Emamekhoo
    Marc S. Ernstoff
    Christopher J. Hoimes
    Brian I. Rini
    Jorge A. Garcia
    Timothy D. Gilligan
    Moshe C. Ornstein
    Petros Grivas
    [J]. Targeted Oncology, 2018, 13 : 599 - 609
  • [10] Immunological Correlates of Response to Immune Checkpoint Inhibitors in Metastatic Urothelial Carcinoma
    Tzeng, Alice
    Diaz-Montero, C. Marcela
    Rayman, Patricia A.
    Kim, Jin S.
    Pavicic, Paul G., Jr.
    Finke, James H.
    Barata, Pedro C.
    Lamenza, Marcelo
    Devonshire, Sarah
    Schach, Kim
    Emamekhoo, Hamid
    Ernstoff, Marc S.
    Hoimes, Christopher J.
    Rini, Brian I.
    Garcia, Jorge A.
    Gilligan, Timothy D.
    Ornstein, Moshe C.
    Grivas, Petros
    [J]. TARGETED ONCOLOGY, 2018, 13 (05) : 599 - 609
12345